These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9158033)

  • 41. Prolongation of islet allograft survival by anti-CD45 antibody pretreatment.
    Shapiro ME; Liu M
    Transplant Proc; 1995 Feb; 27(1):613-4. PubMed ID: 7879119
    [No Abstract]   [Full Text] [Related]  

  • 42. Anti-CD45RB monoclonal antibody prolongs renal allograft survival in cynomolgus monkeys.
    Chen G; Luke PP; Yang H; Visser L; Sun H; Garcia B; Qian H; Xiang Y; Huang X; Liu W; Senaldi G; Schneider A; Poppema S; Wang H; Jevnikar AM; Zhong R
    Am J Transplant; 2007 Jan; 7(1):27-37. PubMed ID: 17227555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
    Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
    Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination therapy with anti-ICOS and cyclosporine enhances cardiac but not islet allograft survival.
    Nanji SA; Hancock WW; Anderson CC; Zhu LF; Kneteman NM; Shapiro AM
    Transplant Proc; 2003 Nov; 35(7):2477-8. PubMed ID: 14611990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Permanent acceptance of mitomycin C-treated islet allograft.
    Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
    Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection.
    Arai K; Sunamura M; Wada Y; Takahashi M; Kobari M; Kato K; Yagita H; Okumura K; Matsuno S
    Int J Pancreatol; 1999 Aug; 26(1):23-31. PubMed ID: 10566155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
    Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
    Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression.
    Ariyan C; Salvalaggio P; Fecteau S; Deng S; Rogozinski L; Mandelbrot D; Sharpe A; Sayegh MH; Basadonna GP; Rothstein DM
    J Immunol; 2003 Dec; 171(11):5673-7. PubMed ID: 14634073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolongation of murine islet allograft survival by pretreatment of islets with 2-chloroadenosine.
    Takeda Y; Satomi S; Miura S; Koja S; Morimoto K; Okazaki H; Taguchi Y; Mori S
    Transplant Proc; 1993 Feb; 25(1 Pt 2):971-2. PubMed ID: 8442285
    [No Abstract]   [Full Text] [Related]  

  • 52. Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1.
    Fiorina P; Jurewicz M; Vergani A; Petrelli A; Carvello M; D'Addio F; Godwin JG; Law K; Wu E; Tian Z; Thoma G; Kovarik J; La Rosa S; Capella C; Rodig S; Zerwes HG; Sayegh MH; Abdi R
    J Immunol; 2011 Jan; 186(1):121-31. PubMed ID: 21131428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
    Brendel MD; Schachner RS; Kong SS; Qian T; Alejandro R; Mintz DH
    Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
    [No Abstract]   [Full Text] [Related]  

  • 54. Prolonged survival of islet allografts in mice treated with rosmarinic acid and anti-CD154 antibody.
    Jung DY; Kim EY; Joo SY; Park JB; Moon C; Kim SH; Sim EY; Joh JW; Kwon CH; Kwon GY; Kim SJ
    Exp Mol Med; 2008 Feb; 40(1):1-10. PubMed ID: 18305392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. alpha4 integrin in islet allograft rejection.
    Stegall MD; Dean PG; Ninova D; Cohen AJ; Shepard GM; Gup C; Gill RG
    Transplantation; 2001 Jun; 71(11):1549-55. PubMed ID: 11435963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
    Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
    Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
    Zhang Z; Zhong R; Jiang J; Wang J; Garcia B; Le Feuvre C; White M; Stiller C; Lazarovits A
    Transplant Proc; 1997; 29(1-2):1253. PubMed ID: 9123294
    [No Abstract]   [Full Text] [Related]  

  • 60. Oleanolic Acid, a plant triterpenoid, significantly improves survival and function of islet allograft.
    Nataraju A; Saini D; Ramachandran S; Benshoff N; Liu W; Chapman W; Mohanakumar T
    Transplantation; 2009 Oct; 88(8):987-94. PubMed ID: 19855244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.